Capillary and arterial cerebral amyloid angiopathy in Alzheimer's disease: defining the perivascular route for the elimination of amyloid beta from the human brain.
about
A new look at cerebrospinal fluid circulationEffect of anti-inflammatory agents on transforming growth factor beta over-expressing mouse brains: a model revisedTheories of schizophrenia: a genetic-inflammatory-vascular synthesisClearance systems in the brain-implications for Alzheimer diseaseVascular, glial, and lymphatic immune gateways of the central nervous systemNonhuman primate models of Alzheimer-like cerebral proteopathyHow Do Meningeal Lymphatic Vessels Drain the CNS?Imaging the Perivascular Space as a Potential Biomarker of Neurovascular and Neurodegenerative Diseases.Imaging and CSF studies in the preclinical diagnosis of Alzheimer's disease.Intracisternal administration of tissue plasminogen activator improves cerebrospinal fluid flow and cortical perfusion after subarachnoid hemorrhage in miceNeurovascular changes measured by time-of-flight MR angiography in cholesterol-fed rabbits with cortical amyloid beta-peptide accumulation.Neurovascular mechanisms and blood-brain barrier disorder in Alzheimer's disease.Structural neuroimaging in Altheimer's disease: do white matter hyperintensities matter?The blood-brain barrier and microvascular water exchange in Alzheimer's disease.High-definition characterization of cerebral β-amyloid angiopathy in Alzheimer's diseasePreventing vascular effects on brain injury and cognition late in life: knowns and unknowns.Amyloid Beta1-42 and the Phoshorylated Tau Threonine 231 in Brains of Aged Cynomolgus Monkeys (Macaca fascicularis).Cortical and leptomeningeal cerebrovascular amyloid and white matter pathology in Alzheimer's diseaseSolutes, but not cells, drain from the brain parenchyma along basement membranes of capillaries and arteries: significance for cerebral amyloid angiopathy and neuroimmunology.Contemplating Alzheimer's disease and the contribution of white matter hyperintensities.Amyloid-beta peptide remnants in AN-1792-immunized Alzheimer's disease patients: a biochemical analysisCerebral amyloid angiopathy: pathogenesis and effects on the ageing and Alzheimer brain.Mechanisms of fluid movement into, through and out of the brain: evaluation of the evidence.The influence of tumour necrosis factor- α (TNF-α) on amyloid-β (Aβ)-degrading enzymes in vitro.Real-time imaging of perivascular transport of nanoparticles during convection-enhanced delivery in the rat cortex.Physiological amyloid-beta clearance in the periphery and its therapeutic potential for Alzheimer's diseaseCerebral Amyloid and Hypertension are Independently Associated with White Matter Lesions in Elderly.Mechanism of cerebral beta-amyloid angiopathy: murine and cellular models.Neurogenesis and alterations of neural stem cells in mouse models of cerebral amyloidosis.Amyloid-beta protein clearance and degradation (ABCD) pathways and their role in Alzheimer's disease.Deposition of amyloid β in the walls of human leptomeningeal arteries in relation to perivascular drainage pathways in cerebral amyloid angiopathy.Rapid in vivo measurement of β-amyloid reveals biphasic clearance kinetics in an Alzheimer's mouse model.Research into the Physiology of Cerebrospinal Fluid Reaches a New Horizon: Intimate Exchange between Cerebrospinal Fluid and Interstitial Fluid May Contribute to Maintenance of Homeostasis in the Central Nervous SystemPopulation studies of sporadic cerebral amyloid angiopathy and dementia: a systematic review.Amyloid beta peptides in human plasma and tissues and their significance for Alzheimer's disease.Endothelin-converting enzyme-2 is increased in Alzheimer's disease and up-regulated by Abeta.Cholesterol retention in Alzheimer's brain is responsible for high beta- and gamma-secretase activities and Abeta production.The "perivascular pump" driven by arterial pulsation is a powerful mechanism for the distribution of therapeutic molecules within the brain.ABCG2 is upregulated in Alzheimer's brain with cerebral amyloid angiopathy and may act as a gatekeeper at the blood-brain barrier for Abeta(1-40) peptides.Perivascular space and neurological disorders.
P2860
Q21195862-A3F5193C-9664-4C36-8B6B-C06580E32D8BQ24796292-2A2782DA-AC81-40C6-BF89-E7CD2ACE8DD6Q24800460-E3C95D6C-3AB8-4631-A2A4-E0F6F837BB2EQ26801541-8D2C77F5-D41B-4D01-88F8-2BB064931A49Q28071461-CE593469-2DB7-43AB-866F-94987DFEEEC9Q28728135-E8E292B6-E5F7-4897-AEC6-69E1A2E158C1Q30276270-A28AD0EA-A8DB-490A-8CDC-E93325030EFFQ31060747-A5CC46D0-FA42-4F77-9A79-B355A832D285Q31108280-B06AB74E-850C-4762-8981-C4B90575A4AFQ33577536-D916EAD7-8269-4387-9D93-0D669F5E572DQ33647172-A60AC091-06ED-4D92-BD0D-D0DEF50C576AQ33782706-98A504F0-E09A-4F86-8F80-6CBAF35C0CC4Q33828173-DEE1A200-9EEE-45EA-B20C-4015DAA0DEADQ33936586-D13415AA-B347-408B-87EA-F87F238AB3F4Q34209319-9DB9FCDA-DC82-4419-8749-37122AE2E338Q34212947-65268996-583C-42A5-95AE-0D65206AFB36Q34479422-B082EF37-7E8F-4519-893E-1DBFE67430A5Q34520661-CACC72DB-6C48-48DF-B538-BC2871115398Q34738708-14E269BB-78E7-406D-85DC-7B231B78D4B0Q35031724-4EA7E8BB-1EB2-41BE-BF22-B692B22305DEQ35222076-D451DAEE-7335-4C8F-A700-D6FB90334A21Q35540373-89B6C4A6-358C-4F7C-B5B8-24E3C0703754Q35560495-73F5E783-DFAC-4225-98B9-B2E42B0FA0C0Q35625868-4DF9A070-0FC3-472A-91A8-D2782A241AFBQ35785766-3E4E53EB-4129-46E7-BBAF-9D2B143C3E2BQ36073671-11929418-202A-4165-BEC1-E2D7FA1B3C15Q36332727-8D128A55-319F-4E72-A256-034BCB005A53Q36448521-5B655FD1-0FB7-4EB9-B3D9-1978F09B7799Q36691059-652D5781-1C38-4E65-A246-5863DA64909AQ36764094-C252E3AB-180B-43ED-BE2A-B4C3250E73CCQ36786388-3F8A5E8A-DE21-40BA-8A6C-9826469451ECQ36863138-7BC7FBB6-206C-404C-A78B-C0788BE9B7F8Q37095901-111DA9C3-3FA2-434A-9E0B-8E434D48879DQ37109969-5C0226FA-6B1A-42FA-A570-D58018804C22Q37145570-BEAD0F74-701F-448E-91B9-F7CEEC640871Q37257169-DE71DB49-FC78-4949-A8E6-8756E940D5ACQ37288781-9007B560-B883-4C2C-9D01-0F3380DD0EC4Q37313963-EA837858-8B05-4D33-B1DC-C7A985C4A589Q37351212-99BB7EFE-7169-4D00-A125-B04455E89EDDQ37384725-D6818CDB-BD57-4159-8E1C-42708C571E0E
P2860
Capillary and arterial cerebral amyloid angiopathy in Alzheimer's disease: defining the perivascular route for the elimination of amyloid beta from the human brain.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Capillary and arterial cerebra ...... oid beta from the human brain.
@en
Capillary and arterial cerebra ...... oid beta from the human brain.
@nl
type
label
Capillary and arterial cerebra ...... oid beta from the human brain.
@en
Capillary and arterial cerebra ...... oid beta from the human brain.
@nl
prefLabel
Capillary and arterial cerebra ...... oid beta from the human brain.
@en
Capillary and arterial cerebra ...... oid beta from the human brain.
@nl
P2093
P1476
Capillary and arterial cerebra ...... oid beta from the human brain.
@en
P2093
P304
P356
10.1046/J.1365-2990.2003.00424.X
P577
2003-04-01T00:00:00Z